Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $38.0100 (-0.21%) ($37.7500 - $39.2800) on Wed. Nov. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.7% (three month average) | RSI | 57 | Latest Price | $38.0100(-0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 3.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.85% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) IGOV(-7%) TBT(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.85% (StdDev 3.7%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $39.22(-3.09%) | 10 Day Moving Average | $38.13(-0.31%) | 20 Day Moving Average | $37.49(1.39%) | To recent high | -6.1% | To recent low | 36.7% | Market Cap | $5.566b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |